ADMA is profitable and ASCENIV is still growing, but Q1 2026 reset the story: standard IG pricing pressure, distributor timing, BIVIGAM weakness, and long-term guidance withdrawal turned 2026 into a proof year.
The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.
